| Ticker Details |
|
Quoin Pharmaceuticals, Ltd.
|
| IPO Date: |
August 1, 2016 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$9.58M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.24 | 5.57%
|
| Avg Daily Range (30 D): |
$0.21 | 3.65%
|
| Avg Daily Range (90 D): |
$0.33 | 4.35%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.6M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
.07M |
| Trade Size |
| Avg Trade Size (Sh.): |
324 |
| Avg Trade Size (Sh.) (30 D): |
115 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Institutional Trades: |
17 |
| Avg Institutional Trade: |
$1.02M |
| Avg Institutional Trade (30 D): |
$1.25M |
| Avg Institutional Trade (90 D): |
$1.25M |
| Avg Institutional Trade Volume: |
.03M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
|
|
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
|
|
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-16.99M
|
$-5M
|
$-4.35M
|
|
Operating Income / Loss
|
|
|
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-.7M
|
$-.69M
|
$1.99M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Apr 09, 2025
|
1:35
|
|
Apr 08, 2025
|
1:20
|
|
Jul 18, 2023
|
1:12
|
|
Jul 17, 2023
|
1:12
|
|
Aug 01, 2022
|
2:25
|
|
Sep 24, 2021
|
1:4
|
|
Oct 23, 2019
|
1:5
|
|
|
|